Exosomes have emerged as one of the most recent promising platforms for drug delivery and therapeutics due to distinctive properties such as innate stability, low immunogenicity, biocompatibility, and excellent tissue or cell penetration capabilities. Moderator Qiongqiong Angela Zhou (CAS) brings together a panel of industry experts to discuss progress in the field, key players, and up-to-date information on the current advancement of clinical applications in cardiovascular, neurological, and lung diseases, as well as the obstacles that need to be addressed.